Patrick Vallance

GSK’s President of Pharmaceutical R&D discusses the challenges of discovering new medicines on BBC Radio 4

Patrick Vallance is something of a rare breed: a game-keeper turned poacher; an academic who's moved over into industry. And not just any industry, but the pharmaceutical industry.

Patrick Vallance, GSK’s President of Pharmaceuticals R&D talks to Professor Jim Al-Khalili on BBC Radio 4’s The Life Scientific about his medical and scientific career, the challenges of discovering new medicines and the research underway at GSK (Original air date: November 2015).

This interview first aired on BBC Radio 4.

 

Related tags

Explore more features

Petri dish with bacteria

Innovation

Turning the tide on antibiotic resistance| New antibiotics

Graphic of bioelectronics

Innovation

Developing biosensors and bioelectronics

Our Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.

Bioelectronic pathways

Behind the science

Leading future science | GSK medical science

Our challenge was to accelerate 10 years to 10 months, fast tracking our research and development.

Back to top